DONALD YEE to Rivaroxaban
This is a "connection" page, showing publications DONALD YEE has written about Rivaroxaban.
Connection Strength
0.180
-
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial. Lancet Haematol. 2020 Jan; 7(1):e18-e27.
Score: 0.151
-
Improving evidence on anticoagulant therapies for venous thromboembolism in children: key challenges and opportunities. Blood. 2015 Dec 10; 126(24):2541-7.
Score: 0.029